Denotes AASLD Presidential Poster of Distinction 225 Phenotypic diversity spanning the spectrum of hepatocyte differentiation impacts the outcome of patients with β-catenin-mutated hepatocellular carcinomas. Romain Desert1, Christelle Reynès2, Robert… Click to show full abstract
Denotes AASLD Presidential Poster of Distinction 225 Phenotypic diversity spanning the spectrum of hepatocyte differentiation impacts the outcome of patients with β-catenin-mutated hepatocellular carcinomas. Romain Desert1, Christelle Reynès2, Robert Sabatier2, Damien Grégoire3, Florian Rohart4, Anne Corlu1, Frédéric Canal5, Marie Sicard1, Mireille Desille1, Stephanie Renaud1, Bruno Turlin1, Laurent Sulpice1, Damien Bergeat1, Pascale Bellaud1, Christine Perret5, Bruno Clement1, Kim-Anh Lê Cao4, Orlando Musso1; 1Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, INSERM, INRA, Univ Rennes, CHU Rennes, Rennes, France; 2Laboratoire de Biostatistique, Informatique et Physique Pharmaceutique, Univ Montpellier, Montpellier, France; 3IGMM, CNRS, Univ Montpellier, Montpellier, France; 4Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia; 5Institut Cochin, INSERM, CNRS, Univ Paris Descartes, Sorbonne Paris Cité, Paris, France
               
Click one of the above tabs to view related content.